Release date: October 23, 2020
Expiration date: October 23, 2023
Estimated Time of Completion: 45 minutes
Description
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
Learning Objectives
After completing this case the reader should be able to:
- Define subclinical hypothyroidism.
- Evaluate a patient’s signs, symptoms, and laboratory results for subclinical hypothyroidism.
- Describe causes of elevated thyroid stimulating hormone other than hypothyroidism.
- Critically review the evidence base supporting therapies for subclinical hypothyroidism.
Target Audience
Directed to primary care physicians including family practitioners and internists.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
American Medical Association (AMA) Cleveland Clinic Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Maintenance of Certification (MOC)
ABA: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
ABIM: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ABOHNS: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.
ABP: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 0.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
ABS: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Activity Director and Faculty
Activity Director
Anthony Fernandez, MD, PhD
Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Medical Co-Director, Center for Continuing Education
Cleveland Clinic
Faculty
Mario Skugor, MD
Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:
| Anthony Fernandez, MD, PhD |
| |
Novartis |
Consulting;
Independent contractor (including contracted research);
Teaching and Speaking
|
| |
Abbvie Pharmaceuticals |
Consulting; Teaching and Speaking |
| |
Celgene Corporation |
Consulting |
| |
Mallinckrodt Inc. |
Independent contractor (including contracted research);
Teaching and Speaking |
| |
Pfizer, Inc. |
Independent contractor (including contracted research) |
| |
Roche Pharmaceuticals |
Principal Investigator for a Phase III Clinical Trial |
The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
Mario Skugor, MD
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education.
